Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation–modified proteins to a conserved motif

Nature Medicine volume 1, pages 1057–1061 (1995)Cite this article

Abstract

Why diabetes is associated with abnormally high susceptibility to infection remains unknown, although two major antibacterial proteins, lysozyme and lactoferrin, have now been shown to specifically bind glucose–modified proteins bearing advanced glycation end products (AGEs). Exposure to AGE–modified proteins inhibits the enzymatic and bactericidal activity of lysozyme, and blocks the bacterial agglutination and bacterial killing activities of lactoferrin. Peptide mapping revealed a single AGE binding domain in lysozyme and two AGE binding domains in lactoferrin; each domain contains a 17– to 18– amino acid cysteine–bounded loop motif (CX15–16C) that is markedly hydrophilic. Synthetic peptides corresponding to these motifs in lysozyme and lactoferrin exhibited AGE binding activity, and similar domains are also present in other antimicrobial proteins. These results suggest that elevated levels of AGEs in tissues and serum of diabetic patients may inhibit endogenous antibacterial proteins by binding to this conserved AGE–binding cysteine–bounded domain ‘ABCD’ motif, thereby increasing susceptibility to bacterial infections in the diabetic population.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Monnier, V.M. & Cerami, A. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science 211, 491–454 (1981).

    Article  CAS  Google Scholar 

  2. Bucala, R., Vlassara, H. & Cerami, A. in Post-Translational Modifications of Proteins (eds Harding, J.J. Crabbe & M.J.C.) Ch 2, 53–79 (CRC Press, Boca Raton, Florida, 1992).

    Google Scholar 

  3. Vlassara, H., Bucala, R. & Striker, L. Pathogenic effects of advanced glycosylation: Biochemical, biological, and clinical implications for diabetes and aging. J. lab. Invest. 70, 138–151 (1994).

    CAS  Google Scholar 

  4. Moutshen, M.P., Scheen, A.J. & Lefebvre, P.J. Impaired immune responses in diabetes mellitus: Analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabetes Metab. (Paris) 18, 187–207 (1992).

    Google Scholar 

  5. Philips, D. The three-dimensional structure of an enzyme molecule. Sci. Am. 215, 78–90 (1966).

    Article  Google Scholar 

  6. Anderson, B., Baker, H.M., Norris, G.E., Rumball, S.V. & Baker, E.N. Apo-lactoferrin structure demonstrates ligand-induced conformational change in transferrins. Nature 344, 784–787 (1992).

    Article  Google Scholar 

  7. Reiter, B. & Oram, J.D. Bacterial inhibitors in milk and other biological fluids. Nature 216, 643–658 (1969).

    Google Scholar 

  8. Tenovuo, J., Lumikari, M. & Soukka, T. Salivary lysozyme, lactoferrin and peroxidases: Antibacterial effects on cariogenic bacteria and clinical applications in preventive dentistry. Proc. Finn. Dent. Soc. 87, 197–208 (1991).

    CAS  PubMed  Google Scholar 

  9. Velikov, V.K. et al. Humoral factors of general and local immunity in diabetes mellitus. Ter. Arkh. 57, 20–22 (1985).

    CAS  PubMed  Google Scholar 

  10. Muratsu, K. & Morioka, T. Levels of salivary lysosyme, lactoperoxidase and lactoferrin in diabetic hamsters. Infect. Immun. 48, 389–394 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Tenovuo, J. et al. Immunoglobulins and innate antimicrobial factors in whole saliva of patients with insulin-dependent diabetes mellitus. J. dent. Res. 65, 62–66 (1986).

    Article  CAS  Google Scholar 

  12. Oberg, G. et al. Bactericidal proteins and neutral proteases in diabetes neutrophils. Diabetologia 29, 426–429 (1986).

    Article  CAS  Google Scholar 

  13. Lechowski, R. et al. Serum lysosyme activity and nitroblue tetrazolium reduction test in dogs with diabetes mellitus. Zentralbl. Veterinaermed. 38, 530–503 (1991).

    Article  CAS  Google Scholar 

  14. Ben-Aryeh, H. et al. Oral health and salivary composition in diabetic patients. J. diabetes Complications 7, 57–62 (1993).

    Article  CAS  Google Scholar 

  15. Makita, Z., Vlassara, H., Cerami, A. & Bucala, R. Immunochemical detection of advanced glycosylation end products. J. biol. Chem. 267, 5133–5138 (1992).

    CAS  Google Scholar 

  16. Soukka, T., Tenovuo, J. & Rundegren, J. Agglutination of Streptococcus mutans serotype C cells but inhibition of Porphyromonas gingivalis autoaggregation by human lactoferrin. Arch. Oral Biol. 38, 227–232 (1993).

    Article  CAS  Google Scholar 

  17. Perillie, P.E. & Finch, S.C. in Lysosyme (eds Osserman, E.F., Canfield, R.E. & Beychok, S.) Ch. 31, 359–372 (Academic, New York and London, 1974).

    Google Scholar 

  18. Schmidt, A.M. et al. Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J. biol. Chem. 267, 14987–14997 (1992).

    CAS  PubMed  Google Scholar 

  19. Vlassara, H., Brownlee, M. & Cerami, A. Novel macrophage receptor for glucose-modified proteins is distinct from previously described scavenger receptors. J. exp. Med. 164, 1301–1309 (1986).

    Article  CAS  Google Scholar 

  20. Casey, J.I. in Diabetes Mellitus Theory and Practice (eds Rifkin, H. & Porte D. Jr) Ch. 37, 617–625 (Elsevier, New York, Amsterdam, London, 1991).

    Google Scholar 

  21. Takada, K., Ohno, N. & Yadomae, T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect. Immun. 62, 1171–1175 (1994).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. Bellamy, W. et al. Identification of the bactericidal domain of LF. Biochim. biophys. Acta 1121, 130–136 (1992).

    Article  CAS  Google Scholar 

  23. Gabay, J.E. & Almeida, R.P. Antibiotic peptides and serine protease homologs in human polymorphonuclear leukocytes: Defensins and azurocidin. Curr. Opin. Immun. 5, 97–102 (1993).

    Article  CAS  Google Scholar 

  24. Lehrer, R.I. Defensins: Antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11, 105–128 (1993).

    Article  CAS  Google Scholar 

  25. Johnstone, A.P., Thunberg, A.L. & Kindt, T.J. Homogeneous rabbit immunoglobulin lacking group a allotypes: Amino acid sequence analysis of the heavy chain. Biochemistry 17, 1337–1343 (1978).

    Article  CAS  Google Scholar 

  26. Mahoney, W.C. & Hermodson, M.A. High-yield cleavage of tryptophophnyl peptide bonds by o-iodosobenzoic acid. Biochemistry 18, 3810–4814 (1979).

    Article  CAS  Google Scholar 

  27. Hopp-Woods method. Analyzed with MacVector 4.0 software, New Haven, Connecticut, and Lasergene, DNASTAR, Madison, Wisconsin.

Download references

Author information

Authors and Affiliations

  1. The Picower Institute for Medical Research, 350 Community Drive, Manhasset, New York, 11030, USA

    Yong Ming Li, Annie X. Tan & Helen Vlassara

Authors
  1. Yong Ming Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Annie X. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Helen Vlassara
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Tan, A. & Vlassara, H. Antibacterial activity of lysozyme and lactoferrin is inhibited by binding of advanced glycation–modified proteins to a conserved motif. Nat Med 1, 1057–1061 (1995). https://doi.org/10.1038/nm1095-1057

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm1095-1057

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing